Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new approach could lead to cancer treatments that are both more precise and have fewer side effects. The technique is still in development but shows great potential for improving cancer therapy. Mutant Proteins and Cancer Some proteins can […]
Source link